MB-07811 clinical trials
Also written VK2809.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2009
How each study uses MB-07811 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
3 studies that test it; most in 2009 (1)
| Year | Studies |
|---|---|
| 2009 | 1 |
| 2016 | 1 |
| 2019 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 3
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 0
Studies
Open first, then newest update. How each study uses MB-07811 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- A Study to Assess the Efficacy and Safety of VK2809 for 52 Weeks in Subjects With Biopsy Proven NASHCompletedPhase 2Viking Therapeutics, Inc.NCT04173065Written as VK2809How we know
- Safety and Tolerability of VK2809 in Patients With Primary Hypercholesterolemia and Non-Alcoholic Fatty Liver DiseaseCompletedPhase 2Viking Therapeutics, Inc.NCT02927184Written as VK2809How we know
- Study of MB07811 in Subjects With HypercholesterolemiaWithdrawnPhase 2Ligand PharmaceuticalsNCT00879112Written as MB07811How we know
Codes
What other systems call MB-07811 · ClinicalTrials.gg INT005411
- Wikidata Q27258223MB-07811One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| Wikidata | Q27258223 | MB-07811 | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.